- Home
- JSPRW vs BTE Comparison
JSPRW vs BTE Comparison
Compare JSPRW & BTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JSPRW
- BTE
- Stock Information
- Founded
- JSPRW N/A
- BTE 1993
- Country
- JSPRW United States
- BTE Canada
- Employees
- JSPRW 45
- BTE N/A
- Industry
- JSPRW Biotechnology: Pharmaceutical Preparations
- BTE Meat/Poultry/Fish
- Sector
- JSPRW Health Care
- BTE Consumer Staples
- Exchange
- JSPRW Nasdaq
- BTE Nasdaq
- Market Cap
- JSPRW N/A
- BTE N/A
- IPO Year
- JSPRW 2020
- BTE N/A
- Fundamental
- Price
- JSPRW $0.15
- BTE $2.64
- Analyst Decision
- JSPRW
- BTE Hold
- Analyst Count
- JSPRW 0
- BTE 1
- Target Price
- JSPRW N/A
- BTE $5.50
- AVG Volume (30 Days)
- JSPRW N/A
- BTE 17.6M
- Earning Date
- JSPRW N/A
- BTE 02-26-2025
- Dividend Yield
- JSPRW N/A
- BTE 2.44%
- EPS Growth
- JSPRW N/A
- BTE N/A
- EPS
- JSPRW N/A
- BTE N/A
- Revenue
- JSPRW N/A
- BTE $2,483,786,964.00
- Revenue This Year
- JSPRW N/A
- BTE $15.08
- Revenue Next Year
- JSPRW N/A
- BTE N/A
- P/E Ratio
- JSPRW N/A
- BTE N/A
- Revenue Growth
- JSPRW N/A
- BTE 39.63
- 52 Week Low
- JSPRW N/A
- BTE $2.19
- 52 Week High
- JSPRW N/A
- BTE $4.08
- Technical
- Relative Strength Index (RSI)
- JSPRW N/A
- BTE 50.90
- Support Level
- JSPRW N/A
- BTE $2.59
- Resistance Level
- JSPRW N/A
- BTE $2.78
- Average True Range (ATR)
- JSPRW 0.00
- BTE 0.10
- MACD
- JSPRW 0.00
- BTE 0.02
- Stochastic Oscillator
- JSPRW 0.00
- BTE 59.09
About JSPRW Japer Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.